Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
0.6732
+0.0032 (0.48%)
At close: Mar 18, 2026, 4:00 PM EDT
0.6729
-0.0003 (-0.04%)
After-hours: Mar 18, 2026, 4:29 PM EDT
Skye Bioscience Market Cap
Skye Bioscience has a market cap or net worth of $22.47 million as of March 18, 2026. Its market cap has decreased by -70.47% in one year.
Market Cap
22.47M
Enterprise Value
-3.10M
1-Year Change
-70.47%
Ranking
Category
Stock Price
$0.67
Market Cap Chart
Since April 11, 2024, Skye Bioscience's market cap has decreased from $356.10M to $22.47M, a decrease of -93.69%. That is a compound annual growth rate of -76.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 22.40M | -6.67% |
| Dec 31, 2025 | 24.00M | -72.06% |
| Dec 31, 2024 | 85.90M | -75.88% |
| Apr 11, 2024 | 356.10M | - |
View and export this data all the way back to 2024. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Senti Biosciences | 24.49M |
| Neuphoria Therapeutics | 24.47M |
| Vistagen Therapeutics | 24.06M |
| Passage Bio | 23.90M |
| Cue Biopharma | 22.34M |
| Marker Therapeutics | 22.18M |
| Citius Pharmaceuticals | 21.53M |
| FibroBiologics | 21.12M |